Medtronic (MDT) Cash & Current Investments (2013 - 2026)

Medtronic has disclosed Cash & Current Investments across 14 years of filings, most recently posting $8.4 billion for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $8.4 billion, up 5.82% year-over-year; the trailing twelve-month figure through Jan 2026 was $8.4 billion (up 5.82% YoY), and the FY2025 annual result was $9.0 billion, up 11.99% from the prior year.
• Cash & Current Investments came in at $8.4 billion for Q1 2026 at Medtronic, up from $8.3 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $11.4 billion in Q4 2022 to a low of $7.7 billion in Q4 2023.
• The 5-year median for Cash & Current Investments is $8.3 billion (2024), against an average of $8.9 billion.
• Across the five-year window, Cash & Current Investments slumped 32.34% in 2023 and climbed 11.99% in 2025, its largest moves.
• Medtronic's Cash & Current Investments stood at $11.4 billion in 2022, then plunged by 32.34% to $7.7 billion in 2023, then increased by 3.3% to $8.0 billion in 2024, then increased by 4.23% to $8.3 billion in 2025, then increased by 0.67% to $8.4 billion in 2026.
• The last three Cash & Current Investments figures came in at $8.4 billion (Q1 2026), $8.3 billion (Q4 2025), and $8.1 billion (Q3 2025), per Business Quant data.